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Key Clinical Message
We describe the case of an esophagopericardial fistula generated after endo-
scopic submucosal dissection in a patient affected by a superficial esophageal
squamous cell carcinoma immediately treated with percutaneous pericardial
drainage and placement of a partially covered self-expanding metal stent that
has been removed using the stent-in-stent technique after 35 days.
Keywords
Cardiac tamponade, endoscopic submucosal dissection, esophageal squamous
cell carcinoma, esophagopericardial fistula, stent-in-stent procedure.
Introduction
The improvement of endoscopic imaging increased the
number of the esophageal superficial tumors detected.
Endoscopic submucosal dissection (ESD) is now widely
considered a valid approach in the treatment of superfi-
cial squamous cell carcinoma of the esophagus (ESCC).
ESD allows an en bloc resection of lesions greater than
20 mm in diameter and provides a reduction in the
recurrence rate compared to endoscopic mucosal resec-
tion (EMR) [1]. ESD is technically more difficult com-
pared to EMR, and also it has a major complication rate.
Esophageal perforation is the major complication with an
incidence of 0–6.9%, and it is burdened with a high mor-
tality rate of 11.9% [1–3]. Intraoperative detection and
treatment of perforation reduce the mortality rate and
prevent a surgical treatment. Conservative management of
iatrogenic esophageal fistulas after ESD is nowadays con-
sidered the first choice of treatment [4]. Currently, the
endoscopic techniques that provide the best exclusion of
an esophageal fistula are the use of self-expanding metal
stents (SEMSs) or the use of an over-the-scope-clipping
system (OTSC System—OVESCO Endoscopy AG). In our
experience, we use OTSC System when there is a small
estimated defect with a maximum diameter of 1 cm and
when the margins are not devitalized [5]; if there is evi-
dence of a larger defect (>1 cm), the best solution is to
place a SEMSs.
Case Report
During an endoscopy for a suspected GERD, a 56-year-
old woman was diagnosed a plane, nonulcerated, slightly
depressed esophageal lesion of the middle thoracic esoph-
agus located at 33 cm from the mouth. This lesion was
classified as a Paris type 0-IIc with a diameter of 20 mm.
Biopsies showed a G1 squamous cell carcinoma. The clin-
ical staging of the lesion based on total body CT scan
and EUS highlighted no submucosal (m1) and no lymph
nodes involvement—cT1aN0M0. The patient’s past his-
tory was otherwise negative. After a multidisciplinary
consulting, we decided to treat the neoplasia with ESD;
the patient was consenting, and we took the informed
consent. The procedure was performed under general
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anesthesia, in supine position, using a single-channel
upper gastrointestinal endoscope; the perimeter of the
lesion was marked using argon plasma coagulation (APC)
spots, and we proceed with the submucosal injection of
0.4% sodium hyaluronate (MucoUp; Johnson and John-
son, Tokyo, Japan) diluted with normal saline solution to
create a submucosal lifting. The lesion was on the left
side of the esophagus end, and the dissection was per-
formed with a step-by-step electrocauterization using
HookKnife (Olympus America) and positioning a trans-
parent cap on the tip of the endoscope to keep the
resected flap of mucosa out of the endoscope view. Dis-
section time was 75 min. At the end of dissection, there
was no evidence of subcutaneous emphysema. Three
rotatable endoscopic clips (Quick Clip 2—Olympus) were
applied to close the mucosal gap. There have been no
salient problems during the first postoperative day, and a
water-soluble contrast X-ray of the esophagus showed a
regular transit without extraluminal presence of contrast
medium. Two days later, 72 h far from the dissection,
the patient started with fluid diet and while she was
drinking water she had a strong retrosternal pain. An
urgent ECG showed a ST elevation in leads II, aVF, and
V4-5-6. The chest X-ray was indicative of the presence of
a pneumopericardium (Fig. 1). The clinical course deteri-
orated rapidly with the appearance of worsening hypoten-
sion and tachycardia. An urgent thorax CT scan with
intravenous and oral contrast medium showed an idrop-
neumopericardium conditioning a cardiac tamponade
with associated pneumomediastinum, reactive bilateral
pleural effusion, and evidence of esophagopericardial fis-
tula (EPF) (Fig. 2). The patient was immediately submit-
ted to a percutaneous pericardial drainage with an
outflow of 60 cc corpuscolated pericardial effusion and
250 cc underpressure air; the critical clinical condition
was rapidly improved. The endoscopy showed a mucosal
interruption due to the fall of the proximal clip. We pre-
ferred to remove the other two clips and so we identified
a full thickness solution in the esophageal wall and we
decide to put a self-expanding partially covered metal
stent (SEMSs) to exclude the fistula from salivary and ali-
mentary transit (Fig. 3). We placed an Ultraflex proximal
release 23 9 18 cm (Boston Scientific, Marlborough,
MA) and a naso-jejunal tube for enteral nutrition. The
procedure was completed by the positioning of two per-
cutaneous pleural drainages. The patient was referred to
an intensive care unit and started parenteral nutrition
and antibiotic therapy (metronidazole 500 mg bid, line-
zolid 600 mg bid, and fluconazole 200 mg die). Three
days after the stent placement, we proceeded with a radi-
ologic study of the esophagus using water-soluble con-
trast and there was no evidence of extraluminal spreading
and also no evidence of periprosthetic leak so the patient
started with a soft diet and she was discharged from hos-
pital 6 days later. The pericardial drainage was kept in
place 4 days to obtain a complete resolution of air out-
flow and the appearance of pericardial clear serum. We
did not perform pericardial antiseptic washes through the
pig-tail. In our experience, we are used to leave the stent
in place at least 30–40 days because the average time of
healing of the esophageal fistulas is 3–4 weeks, as
described in literature [6]. The endoscopic evaluation
after 35 days showed a complete epithelialization of prox-
imal and distal uncovered part of the stent, and it was
not possible to remove the device. According to the
stent-in-stent procedure, we positioned a second self-
expanding fully covered stent of the same size and length,
in order to obtain the necrosis of the tissue between the
stents induced by compression and easily remove the
stent few days later [7, 8]. The stent-in-stent positioning
was performed under radioscopic control using a proxi-
mal release stent. After 7 days, we rapidly removed the
fully covered stent and we observed an almost complete
necrosis of the ingrowth tissue in the distal part of the
deep esophageal prosthesis but an incomplete visualiza-
tion of the proximal one. We decide to remove the stent
taking the highly visible green suture positioned at the
distal end of the stent inducing a caudo-cranial intussus-
ception of the stent. The endoscopic evaluation after
removal showed a complete closure of the esophageal
wall defect. The next day, the patient started with a semi-
solid diet and she was discharged in 48 h later. The
Figure 1. Chest x-ray shows the presence of pneumopericardium and
a thin right subphrenic sickle air without evidence of pneumothorax.
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histologic report of the specimen showed a complete
abscission of the esophageal lesion confirmed as a G1
squamous cell carcinoma—pT1a. An esophagogastroduo-
denoscopy performed 3 months after was negative for
recurrence and esophageal stenosis.
Discussion
Temporary stent placement can be considered for treating
esophageal leaks, fistulas, and perforations, but the opti-
mal stenting duration remains unclear and should be
individualized according to personal experience. The
European Society of Gastrointestinal Endoscopy (ESGE)
recommends for the removal of embedded partially cov-
ered esophageal prosthesis the use of stent-in-stent tech-
nique (strong recommendation, low quality of evidence)
[9]. The choice of a large and partially covered stent is
due to the fact that in our experience, the wide proximal
calyx (28 mm of diameter) and the absence of external
covering allow a rapid reimbursement of the stent to the
esophageal wall; the compression of the mucosa facilitates
the growth of granulation tissue that stabilizes the stent
avoiding the distal migration. However, we know that the
removal of this type of stent could be difficult. The use of
covered self-expandable metal stents could also be consid-
ered as a good choice of treatment of esophageal fistulas
and leaks [10]. The use of fully covered stents is however
burdened by a greater incidence of distal migration and
periprosthetic endoleak. On the other hand, the removal
of covered stents is easier and less dangerous.
In our experience, 13 consecutive patients underwent
conservative treatment of esophageal fistula using partially
covered SEMSs (Boston Scientific) (n = 6) or over-the-
scope-clipping system (OTSC System—OVESCO Endo-
scopy AG) (n = 7). For small defects with a maximum
diameter of 1 cm, we used OTSC System, but when there
was evidence of a larger defect (>1 cm), we preferred to
place a SEMSs [5]. We have treated six patients with the
stent-in-stent technique. The first SEMSs remained in
place for a median of 39 days (range 18–68) without dis-
placement. All stents were left in place for a median of
9 days. The overall stent-in-stent success rate was 100%
for the removal of embedded stents. No serious adverse
events related to the procedure occurred. We observed a
100% success rate in the closure of the fistula. We con-
sider the procedure safe, well tolerated, and effective. The
use of a covered Ultraflex stent of the same size as the
old stent for a limited time (<8 days) was consistently
successful. In case of ineffective liberation of the proximal
calyx of the stent, its removal for caudo-cranial intussus-
ception is possible and sometimes essential. We used this
Figure 2. Chest CT scan with intravenous (A) and oral contrast medium (B) shows an idropneumopericardium (A, B arrows),
pneumomediastinum, esophagopericardial fistula (C arrow), and bilateral pleural effusion.
Figure 3. Endoscopic view of the full thickness esophageal fistula that
involves 1/4 of the circumference on the left side of the esophagus.
ª 2017 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. 3
D. Bona et al. Management of esophagopericardial fistula
maneuver twice, and we consider that it allows to avoid a
longitudinal traction on the proximal part of the stent
facilitating a tissue detachment from the prosthesis exert-
ing a centripetal force of much lower magnitude. Conser-
vative management of EPF occurred during ESD and
treated with esophageal stenting and pericardial drainage
is feasible and safe. The use of partially covered stent has
to be reserved at the time in specialized centers because
of possible technical difficulties during the removal.
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We describe the case of an esophagopericardial fistula generated after endoscopic submucosal dissection in a patient
affected by a superficial esophageal squamous cell carcinoma immediately treated with percutaneous pericardial drainage
and placement of a partially covered self-expanding metal stent that has been removed using the stent-in-stent technique
after 35 days.
